Navigation Links
Preventing climate change: The size of the energy challenge
Date:1/7/2013

tmosphere at industrial scale", said Caldeira. "The original study showed that we can solve a large part of the problem with existing technologies, but solving the whole problem requires new technologies deployed at massive scale."

Current technologies and systems cannot provide the equivalent amounts of carbon-free energy needed soon enough or affordably enough to achieve this transformation, the perspective says. Fundamental, disruptive changes to the global energy system are required.

"Most of the greenhouse gas emissions expected this century are expected to come from the developing world in the second half of the century. A central challenge of the first half of this century is to develop the energy technologies that will be needed in the second half of the century," Caldeira said. "Existing technologies just cannot provide the massive amounts of carbon-neutral power needed later this century. Solving the climate problem will be both difficult and necessary."


'/>"/>

Contact: Ken Caldeira
kcaldeira@carnegiescience.edu
650-704-7212
Carnegie Institution
Source:Eurekalert

Page: 1 2

Related biology news :

1. Preventing prostate cancer through androgen deprivation may have harmful effects
2. Microscopic packets of stem cell factors could be key to preventing lung disease in babies
3. New study to examine ecological tipping points in hopes of preventing them
4. Limiting TV time -- Effective strategy for preventing weight gain in children
5. Preventing the immune system from going haywire during sepsis
6. Preventing home invasions means fighting side-by-side for coral-dwelling crabs and shrimp
7. As climate warms, bark beetles march on high-elevation forests
8. Pics, shoots and leaves: Ecologists turn digital cameras into climate change tools
9. Geo-engineering against climate change
10. University of Tennessee study predicts extreme climate in Eastern US
11. Boreal bird species of conservation concern affected by climate change
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... TORONTO , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the ... announced the launch of its new website design. ... in its infancy", says Peter O,Neill , founder and ... ever, the industry needs involvement from the key players on ...
(Date:1/22/2015)... man-made form of insulin delivered by nasal spray may ... with mild cognitive impairment and Alzheimer,s disease dementia, according ... Forest Baptist Medical Center. The study,s subjects ... (MCI) or mild to moderate Alzheimer,s dementia (AD). Those ...
(Date:1/22/2015)... , Europe,s ... European Patent Office to present a video retrospective of the most ... featured: Christofer Toumazou and Sophie Wilson   ... of the Award   Starting on 22 January 2015 ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3
... easier to find things claiming to be sustainable than it ... University geographer is trying to pin down exactly what sustainability ... it. Her goal is to better understand what is important ... sustain with the hope that this will later help civic ...
... St. Joseph, Michigan A new internet-based tool for ... involved and to optimize design by allowing rapid development ... issue of Resource: Engineering & Technology for a ... Biological and Agricultural Engineering at the University of Missouri, ...
... Osteoporosis Foundation (IOF) today shows that osteoporosis is a serious ... 14 Asian countries, regions or territories, ,The Asian Audit, is ... countries as well as collectively across the region. The report,s ... is predicted for Asia as a whole , Already hip ...
Cached Biology News:K-State geographer working to clarify what sustainability really means to rural decision-makers 2Web-based innovation improves, eases agricultural terrace design 2New report shows rising tide of fractures in Asia 2New report shows rising tide of fractures in Asia 3
(Date:2/27/2015)... Nova Scotia (PRWEB) February 27, 2015 ... stage vaccine and immunotherapy company, today announced that ... its application for Fast Track designation and Phase ... vaccines, in conjunction with the mutual co-development agreement ... previously obtained Fast Track designation for the DPX-Survivac. ...
(Date:2/27/2015)... February 27, 2015 Cytokinetics, Incorporated (Nasdaq: ... February 28 with patients and health care advocates in ... Rare Disease Day®. Rare Disease Day is dedicated ... attention to the special challenges faced by patients with ... “Cytokinetics is proud to stand alongside patients and caregivers ...
(Date:2/26/2015)... Feb. 26, 2015  23andMe, the leading personal genetics ... as Privacy Officer and Corporate Counsel. Black brings ... laws as well as health care regulations. As a ... be responsible for reviewing, updating and enhancing the company,s ... and abroad. She joined the company January 5, 2015 ...
(Date:2/26/2015)... Fla. , Feb. 26, 2015 DuPont ... growth priorities driven by key research advancements and product ... at today,s Bank of America Merrill Lynch 2015 Global ... the challenge of building grain supplies the last two ... continue at the pace of the last decade, when ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 623andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5
... The U.S. Food and Drug,Administration (FDA) has ... treatment for complicated intra-abdominal and complicated urinary,tract ... a wide range of Gram-positive(1) and Gram-negative(2),bacteria ... serious infections. DORIBAX belongs to a ...
... 15 Wyeth,Pharmaceuticals, a division of Wyeth (NYSE: ... today at the 63rd Annual Meeting of the ... who received 100 mg/day or,150 mg/day of desvenlafaxine, ... significant reduction in moderate to severe,vasomotor symptoms (VMS) ...
... Telik, Inc.,(Nasdaq: TELK ) announced that ... the partial hold on TELCYTA(R) (canfosfamide HCl, TLK286),clinical ... TELCYTA data by,the agency and permits the resumption ... Palo Alto, CA is a biopharmaceutical company focused ...
Cached Biology Technology:FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections 2FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections 3FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections 4FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections 5Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo 2Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo 3Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo 4Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo 5FDA Removes Partial Hold on TELCYTA Clinical Development 2
quantitation of phosphatase activity, evaluation of hits and leads from HTS...
... Quality ISO 9001:2000 Certified USDA Research ... Validated, SOP's Training AALAS Certified ... All Procedures GLP Documentation Upon Request ... shopping point for all your custom immunology ...
Request Info...
Request Info...
Biology Products: